Acorda Therapeutics, Inc. Convertible Debt, Current
Acorda Therapeutics, Inc. had Convertible Debt, Current of $191.47 million as of 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:ConvertibleDebtCurrent · last filed 2024-05-14
- 2024-03-31: Convertible Debt, Current $191.47M.
- 2023-12-31: Convertible Debt, Current $186.14M.
- 2022-12-31: Convertible Debt, Current $0.00.
| Period end | Convertible Debt, Current |
|---|---|
| 2024-03-31 | $191.47M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $186.14M 10-Q · filed 2024-05-14 |
| 2022-12-31 | $0.00 10-K · filed 2024-04-01 |